PCF Pharma Compliance Congress XIX Agenda and Brochure Now Available

Press Release: PCF Pharma Compliance Congress XIX Agenda and Brochure Now Available

Sponsored by the Pharmaceutical Compliance Forum

November 7 - 9, 2018

Onsite at the Mandarin Oriental, Washington, DC

Online in Your Own Office or Home Live via the Internet with 24/7 Access for Six Months

Media Partners: Harvard Health Policy Review, Health Affairs and Life Sciences Compliance Update

www.PharmaCongress.com

PRESS RELEASE
Phone: 800-503-7419
Email: registration@hcconferences.com
Website: www.PharmaCongress.com

AGENDA AND BROCHURE NOW AVAILABLE

Click here to view the agenda.
Click here to view the brochure.

EARLY BIRD REGISTRATION
- SAVE UP TO $400 -

WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- SEPTEMBER 5, 2018: The Pharmaceutical Compliance Forum's Nineteenth Pharmaceutical and Medical Device Compliance Congress, www.PharmaCongress.com, will be held November 7 - 9, 2018 at the Mandarin Oriental in Washington, DC. Registrants may attend the event in person or online (live webcast and archived for 6 months).

KEYNOTE SPEAKERS

Thomas W. Abrams, RPh, MBA Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Silver Spring, MD	Leslie Backschies, MA Supervisor Special Agent and Unit Chief, International Corruption Unit, Federal Bureau of Investigation, Los Angeles, CA	Richard Bistrong, MA Chief Executive Officer, Front-Line Anti-Bribery LLC, Contributing Editor, FCPA Blog, Former Confidential Human Source (CHS) and Cooperating Witness, FBI and US DOJ, Former Cooperating Witness, City of London Police, HMRC and CPS, UK, New York, NY, USA
Hui Chen, JD Ethics and Compliance Advocate and Consultant, HC Ethics LLC; Former Compliance Counsel Expert (Consultant), US Department of Justice; Former Assistant General Counsel, Pfizer, New York, NY	Zachary A. Cunha, JD Assistant US Attorney and Chief, Civil Division, US Attorney's Office, District of Rhode Island, US Department of Justice, Former AUSA, District of Massachusetts and Eastern District of New York, Providence, RI	Susan Dentzer President and Chief Executive Officer, NEHI, (The Network for Excellence in Health Innovation), Analyst on Health Policy, The NewsHour, Former Editor, Health Affairs, Washington, DC
Jacob Elberg, JD Assistant US Attorney, US Attorney's Office, District of New Jersey, US Department of Justice, Newark, NJ	Christopher B. Harwood, JD Assistant US Attorney and Chief of the Civil Health Care Fraud Unit, US Attorney's Office, Southern District of New York, Former Assistant US. Attorney, US Attorney's Office for the District of Columbia, US Department of Justice, New York, NY	Tarek Helou, Esq. Assistant Chief, FCPA Unit, Fraud Section, Criminal Division, US Department of Justice, Washington, DC

Rachael Honig, JD First Assistant US Attorney, US Attorney's Office for the District of New Jersey, Former Corporate Counsel, Litigation, Celgene, New York, NY	Mary E. Riordan, Esq. Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Washington, DC
Gregg Shapiro, JD Assistant US Attorney, US Attorney's Office, District of Massachusetts, US Department of Justice, Boston, MA	Sally Q. Yates, JD Partner, King and Spalding, Former Acting Attorney General, Former Deputy Attorney General, Former Assistant US Attorney, US Attorney's Office, Northern District of Georgia, US Department of Justice, Washington, DC

AGENDA-AT-A-GLANCE

WEDNESDAY, NOVEMBER 7

FEATURING AN INVITATION-ONLY CCO ROUNDTABLE

Hosted by PCF and PhRMA CCO Working Group; Featuring Hui Chen, JD, HC Ethics LLC

PRECONFERENCE SESSIONS

Patient Support Programs: Risk and Risk Management Best Practices
Practical Approaches to Handling Investigations
Advanced Strategies in Auditing and Monitoring
Asking the Right Risk Questions to Power your Advanced Analytics Strategy

PLENARY SESSIONS

OIG Keynote Address
FDA Keynote Address
Risks Your Risk Assessment Might Miss
Chief Compliance Officer Roundtable

THURSDAY, NOVEMBER 8

PLENARY SESSIONS

Sally Yates Keynote Address
Annual AUSA Roundtable
Annual Qui Tam Roundtable
DOJ, FBI and SEC FCPA Enforcement Update
Patient Support Programs Roundtable
Pharma and Device Pricing and Cost Containment

MINI SUMMITS

Fostering a Culture of Ethics and Compliance
Global Compliance Function Harmonization
Third Party Lifecycle Management
Annual Medical Device Compliance Roundtable

MINI SUMMITS, CONTINUED...

Dissecting Recent CIAs and Review of Draft Model CIA
Strategies to Measure Effectiveness, Monitor and Report
Managing Promotional Programs and Patient Advocacy Groups
Open Payments: Where Does the Sun Shine Now?
Interactions with Specialty Pharmacy
Is your Board Bored of your Compliance Dashboards?
Next Generation Data Analytics Promotion with Medical Professionals: Avoiding White Coat Marketing
Market Access Compliance Considerations
Global Documentation Framework
R&D: Hidden Risks beyond Clinical Trail Recruitment
Compliance for Small to Mid-size Pharma and Device Companies
Compliance Issues Associated with PBM Relationships
Risk Assessments and Mitigation Plans
"All in Compliance" -- Aligning with Your Business Partners
Navigating the Murky Waters of Patient Programs
Compliance for "Evolved" Products, including Aesthetics and Gene Therapy
Best Practice in HCP/HCO Management
Compliance Considerations in Value-based Contracting
Risks and Opportunities related to Medical Affairs
An Interactive Case Study in Effective Crisis Management
Privacy and Cybersecurity Compliance Update, including GDPR
The Compliance Training Revolution

FRIDAY, NOVEMBER 9

INDUSTRY-ONLY BEST PRACTICES ROUNDTABLE

Featuring AUSA Gregg Shapiro, JD

FEATURED SESSION: ANNUAL CCO ROUNDTABLE WITH

Jill Fallows-Macaluso, JD Chief Compliance Officer and Vice President, Novo-Nordisk, Princeton, NJ	Indrani M. Lall Franchini, JD Executive Vice President & Chief Compliance Officer, Alexion Pharmaceuticals, Inc., Former Assistant General Counsel, Pfizer, New York, NY	Jonathon Kellerman Executive Vice President, Global Chief Compliance Officer, Allergan PLC, Former Partner, PwC, Parsippany, NJ
Puja Leekha, JD Vice President, Chief Compliance Officer and Corporate Counsel, Corporate Compliance, Lundbeck Pharmaceuticals LLC, Former Division Legal Counsel & Compliance Officer, Stryker Corporation, Deerfield, IL	Lori Queisser Sr VP and Global CCO, Teva, Former Sr. VP Global Compliance & Business Practices, Schering-Plough, Former VP & CCO, Eli Lilly, Former Co-chair, PCF, Horsham, PA	Paul Silver Principal, Regulatory & Compliance Life Sciences Leader, Deloitte Advisory, Deloitte, Atlanta, GA (Moderator)

FEATURED FACULTY

James Accumanno, JD Director Risk, Monitoring and Auditing, Novo Nordisk, Former Associate Counsel, Bayer, Philadelphia, PA	Anthony Alvizu, CPA, EnCE, CFE Managing Director, Global Risk & Investigations Practice (GRIP), FTI Consulting, Chicago, IL	Eliza L. Andonova, JD Counsel, Hogan Lovells, Washington, DC	Timothy Ayers, JD, MPH Vice President, Chief Compliance Officer, Horizon Pharma PLC, Former VP, Chief Compliance Officer, Dendreon, Chicago, IL
Eric Baim, JD Managing Director, Dovetail Consulting Group, LLC, Former VP, Head of US Compliance, Shire, Boston, MA	Yogesh Bahl, CPA, MBA Managing Director, Alix Partners, New York, NY	Minna Bak, MBA Senior Manager, Helio Health Group, New York, NY	Jennifer Barbre, MA Executive Director, Compliance, Spectrum Pharmaceuticals, Inc., Former Director, Compliance and Ethics Program, Avanir, Former Director, Commercial Compliance, Boehringer Ingelheim, Irvine, CA
Dennis K. Barnes, JD, MBA, CPA Vice President, Global Governance, Risk and Compliance, Mayne Pharma; Former Vice President, Compliance and Risk Management, Global Compliance Officer, PAREXEL; Raleigh-Durham, NC	Scott Bass, JD Partner and Head, Global Life Sciences Team, Sidley Austin LLP, Chicago, IL	Ann Beasley, JD Director, Life Sciences, Governance, Risk & Compliance, Navigant, Former Senior Vice President, Chief Compliance Officer, Biogen, Boston, MA	Thomas Beimers, JD Partner, Hogan Lovells, Former Senior Counsel, Office of Counsel to the Inspector General, US DHHS, Former Special Assistant United States Attorney, US Attorney's Office, Eastern District of Michigan, Minneapolis, MN and Washington, DC
Wanda Bell, CHC Director HCP Compliance, Nestle Skin Health, Former Director Commercial Compliance, Depomed, Former Director, Compliance, Elan, Former Compliance & Ethics Leader, AstraZeneca, Fort Worth, TX	John T. Bentivoglio, Esq. Partner, Skadden Arps LLP; Former Special Counsel for Healthcare Fraud, and Chief Privacy Officer, US Department of Justice; Washington, DC	Brian A. Bohnenkamp, MHA, JD Partner, FDA & Life Sciences Practice, King & Spalding LLP, Washington, DC	Kathleen Boozang Dean and Professor of Law at Seton Hall Law, Newark, NJ
Christine N. Bradshaw, JD Vice President, Porzio Life Sciences, LLC, Principal, Porzio, Bromberg & Newman PC, Morristown, NJ	Julianne Brierley Director, Head of Compliance Learning, Novartis, New York, NY	Katherine Buckley, MBA Partner, Pharmaceutical and Life Sciences Advisory Practice, PwC, Philadelphia, PA	Ed Buthusiem, JD Managing Director, Berkeley Research Group, Adjunct Professor Of Law, Temple University, Former SVP, R&D Legal Operations & Vaccines, GSK, Devon, PA
Joseph Calarco Chief Compliance Officer at Neos Therapeutics, Inc., Philadelphia, PA	Christie Camelio Vice President and US Healthcare Compliance Officer, Celgene, Former Head of Risk Management, Novartis, Summit, NJ	Regina G. Cavaliere, JD Principal, Regulatory Enforcement & Compliance, Life Sciences Sector, KPMG LLP, Former VP and CCO, Otsuka America, Short Hills, NJ	Nicole Chandonnet, JD Associate, Covington & Burling, Washington, DC
William Connelly, JD Senior Counsel, Amgen; Former Staff Attorney, US DHHS, Washington, DC	Brian Conner Vice President, Head of Corporate Compliance, Strongbridge Biopharma plc, Trevose, PA	Kellie Branson Combs, JD Counsel, Ropes & Gray LLP, Washington, DC	Thomas Costa, JD Member, US Board of Directors, Sanofi; Former Vice President, US Compliance & Ethics, Bristol-Myers Squibb, Washington, DC
Clarissa Crain Senior Manager, Life Sciences Advisory, Deloitte, Philadelphia, PA	Paul Curtin Vice President, Global Chief Compliance Officer, Intercept Pharmaceuticals; Former Compliance Officer Global Research and Development, Allergan f/k/a Actavis, New York, NY	Jill Dailey, MBA, JD Vice President & Chief Compliance Officer, Incyte, Former AG, Asia Pac Lead, Pfizer, Former Head, US Ethics and Compliance, Novartis, New York, NY	Meenakshi Datta, JD Partner and Global Co-leader, Healthcare Practice, Sidley Austin LLP, Chicago, IL
Mahnu V. Davar, JD Partner, Arnold & Porter Kaye Scholer LLP, Lecturer, University of Pennsylvania Law School, Fellow, Salzburg Global Seminar, Washington, DC	BJ D'Avella Senior Manager, Life Sciences Regulatory and Operational Risk, Deloitte & Touche LLP, Atlanta, GA	Sharon R. Delshad, JD Director, Compliance and Legal Affairs, Nalpropion, Former Director, Compliance and Legal Affairs, Orexigen Therapeutics, San Diego, CA	Gary Del Vecchio Health Care CO Cardiovascular & Metabolism, Janssen, Former ED US Pharma Compliance & Ethics, Bristol-Myers Squibb, Former PCF Co-chair, New York, NY
Mark A. DeWyngaert, MBA, PhD Managing Director, Life Sciences Regulatory and Operational Risk, Deloitte & Touche LLP, New York, NY	Sarah diFrancesca, JD Partner, Health Care and Life Sciences Regulatory Practice, Cooley, LLP, New York, NY	Christian A. Dingler Managing Consultant, Navigant Consulting, Richmond, VA	Stefanie A. Doebler, JD Of Counsel, Covington & Burling LLP, Washington, DC
Suzanne E. Durrell, JD Partner, Whistleblower Law Collaborative, Taxpayers Against Fraud Education Fund, 2017 Whistleblower Lawyer of the Year, Boston, MA	Michael Dusseau Vice President, Compliance Operations, Allergan, Former Vice President, Compliance, Bayer, Former Divisional Compliance Officer, Merck, Madison, NJ	Eileen Erdos Principal, Forensic and Integrity Services, Ernst & Young LLP, Chicago, IL	Margaret Feltz, JD, MA Vice President, Ethics and Compliance, Purdue Pharma LP, Former PCF Co-chair, Stamford, CN
Alison Fethke, JD Counsel, Ropes & Gray LLP, Former Division Counsel, Legal, Regulatory and Compliance, AbbVie, Chicago, IL	Kellie Fidler, MBA, PMP Director, Global Compliance Risk Mitigation & Monitoring Strategy, Bristol-Myers Squibb, Princeton Pike, NJ	Francisco Ribeiro Filho, MBA Senior Director & Head of US Compliance, Tesaro, Inc., Former Sr. Dir., Corporate Compliance, Biogen, Former Sr. Dir., International Markets, Sandoz, Boston, MA	Paul Fishman, JD Partner and Head, Crisis Management and Strategic Response Team, Arnold & Porter LLP, Former United States Attorney, District of New Jersey, Washington, DC
Paul Flanagan, JD Assistant Professor of Law, Thomas R. Kline School of Law, Drexel University, Former Chief Compliance and Privacy Officer, 21st Century Oncology, West Chester, PA	Sarah A. Franklin, JD Partner, Covington & Burling LLP, Former Attorney, Federal Trade Commission, Washington, DC	Alex Ganz, JD Senior Manager of Compliance, Aegerion Pharmaceuticals, Former Compliance Manager, Shire and Vertex, Boston, MA	Nereyda Garcia, JD Global Heath, Ethics and Compliance, Alnylam Pharmaceuticals, Former Sr. Director, Compliance, Biogen Idec, Cambridge, MA
Gary F. Giampetruzzi, Esq. Partner, Paul Hastings; Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc.; New York, NY	Virginia "Ginny" A. Gibson, JD Partner, Hogan Lovells LLP, Former First Assistant U.S. Attorney, Eastern District of Pennsylvania, US Department of Justice, Philadelphia, PA	Jonathan Glazier, JD, MBA Head, Legal Compliance, Philips, Former Sr. Dir., Corporate Compliance and Privacy Officer, Fresenius, Andover, MA	Wendy C. Goldstein, JD Partner, Health Care and Life Sciences Regulatory Practice, Cooley, LLP, New York, NY
Anthony Greco, MBA Director, Pharmaceutical & Life Sciences Advisory Services, PwC, Philadelphia, PA	Adam Greene, JD, MPH Partner and Co-chair, Health Information & HIPAA Practice, Davis Wright Tremaine LLP, Former Senior Health Information Technology and Privacy Specialist, Office for Civil Rights, DHHS, Washington, DC	Lillian S. Hardy, JD Partner, Hogan Lovells LLP, Washington, DC	Patricia J. Harned, PhD Chief Executive Officer, ECI (Ethics and Compliance Initiative), Former President, Ethics Resource Center, Washington, DC
Kate Heinzelman, JD Counsel, Sidley Austin LLP, Former Deputy GC, US DHHS, Former Special Assistant and Associate Counsel, President Barack Obama, Washington, DC	Laura G. Hoey, JD Co-leader, Government Enforcement and White Collar Group and Health Care and Life Sciences Industry Group, Ropes & Gray LLP, Boston, MA	Christine Hood Director, Learning and Development, Chiesi, Former District Sales Manager, Boehringer Ingelheim, Former Sales Trainer, Biovail, Apex, NC	David Horowitz, JD Partner, Hogan Lovells LLP, Former Deputy General Counsel, DHHS, Washington, DC
Casey J. Horton, CFE Director, Life Sciences, Governance, Risk & Compliance, Navigant, Chicago, IL	Becky Hsiao, JD Senior Legal Manager, Americas Region, Diabetes Group, Medtronic, Los Angeles, CA	Emily Huebener, MA Forensic and Integrity Services, Ernst & Young LLP, Chicago, IL	Erinn Hutchinson Partner, Advisory Services, PwC, Philadelphia, PA
Michael Joachim, JD Global Business Partner, Ethics & Business Integrity, Sanofi Genzyme, Cambridge, MA	Elizabeth Jobes, JD Head, Corporate Compliance & Legal Counsel, Spark, Former Senior VP & CCO, Auxilium, Former PCF Co-chair, Philadelphia, PA	Darren R. Jones Partner, Global Compliance Consulting Leader, Polaris Management, New York, NY	Marci Juneau, MBA Partner, Helio Health Group, Atlanta, GA
Kiley Smith Kelly, MBA Partner, Forensic and Integrity Services, Ernst & Young LLP, Philadelphia, PA	Keith M. Korenchuk, JD, MPH Partner, Arnold & Porter LLP, Washington, DC	Daniel A. Kracov, JD Partner, Arnold & Porter Kaye Scholer LLP, Washington, DC	Daryl Kreml, JD VP & CCO, Sage, Former Head, US Compliance & Global Program Management, Biogen, Former Dir. & Sen. Managing Counsel, Int'l Compliance, Boston Scientific, Boston, MA
Bharathram Lakshmivarahan, MBA Life Sciences Strategy & Operations Consultant, PwC, San Francisco, CA	Marc Levine Director of Compliance, Insightec, Former Compliance Officer, Stryker Corporation, Former Business Conduct Specialist, MAKO Surgical, Fort Lauderdale, FL	Jonathan Levy, JD Corporate Compliance Lead, Spark Therapeutics; Former Associate Director of Compliance and Ethics, US Pharmaceuticals, Bristol-Myers Squibb; Philadelphia, PA	Jodi Lindsey, JD Senior Director & Head of US Healthcare Compliance, Alkermes, Former Associate Director, Commercial Compliance, Biogen, Boston, MA
Richard Liner, JD Senior Counsel, Compliance and Investigations, Bayer, Whippany, NJ	Chad Londeree Healthcare Industry Group Leader, SAI Global, Richmond, VA	Pamela Lonzer, MSJ Ass. Dir., Medical Operations, Compliance & Controls, Alexion, Former Ass. Dir. & US Medical Advisor, Global Compliance & Risk Management, Shire, Chicago, IL	Seth H. Lundy, JD Partner, King & Spalding, Washington, DC
Ali Lyons Director, Ethics and Compliance, Aegerion, Former Director, Operations, Ethics and Compliance, Eli Lilly, Cambridge, MA	Joe Mack, JD Senior Compliance Counsel, Bayer, Former Assistant United States Attorney and Deputy Chief, Health Care and Government Fraud Unit, US Attorney's Office, District of New Jersey, New York, NY	Colette G. Matzzie, JD Partner, Phillips & Cohen LLP, Former Staff Attorney, Public Citizen Litigation Group, Former Trial Attorney, Tobacco Litigation Team, US Department of Justice, Washington, DC	Dennis McCloskey, JD Compliance Officer, Olympus Corporation of the Americas, Former Assistant District Attorney, Homicide Unit, Philadelphia District Attorney's Office, Philadelphia, PA
Vickie L. McCormick Vice President, Janssen U.S. Commercial Health, Care Compliance & CIA Operations, Johnson & Johnson, Former Chief Compliance Officer, St. Jude Medical, Titusville, NJ	Jennifer McGee, JD Vice President and Chief Compliance Officer, Otsuka America Pharmaceutical, Inc., Rockville, MD	Jean McKiernan, MBA Director, Pharmaceutical and Life Sciences Advisory Practice, PwC, Chicago, IL	Jason P. Mehta, JD Partner, Bradley Arant Boult Cummings LLP, Former Assistant United States Attorney, US Attorney's Office for the Middle District of Florida, US Department of Justice, Tampa, FL
Kathleen Meriwether, JD Principal, Fraud Investigation and Dispute Services, EY, Former Assistant United States Attorney, Eastern District of Pennsylvania, US Department of Justice, Philadelphia, PA	Brian Miller, PhD Dir. Compliance Training and Documentation, Otsuka, Former Senior Mgr, Learning Technologies, AstraZeneca, Former Ass. Dir. Learning Design & Technology, Merck, Princeton, NJ	Vahan Minassian, JD Director, US Promotional Monitoring Lead, Pfizer, Philadelphia, PA	Melissa Murphy, MBA Senior Compliance Specialist, Office of Ethics & Compliance, Medtronic, Minneapolis, MN
Katherine Cartwright Norris, MPA Dir., Berkeley Research Group, Former Sr Dir., Compliance, NSF Health Sciences, Former Dir., Corporate Compliance, Spectranetics, Washington, DC	Chrisoula Nikidis Canadian Head of Compliance and Ethics Solutions, IQVIA; Former Executive Director, Ethics and Compliance, Innovative Medicines Canada; Former Industry Co-Chair Designate, APEC Biopharmaceutical Working Group on Ethics, Ottawa, Canada	Adam Oakley Director, Potomac River Partners, Arlington, VA	Josh T. O'Harra, MS, JD Assistant General Counsel, Eli Lilly and Company; Former Sr. Associate, King & Spalding, Washington, DC
Agatha O'Malley, MStPH, JD Privacy Officer and Senior Counsel, Otsuka Pharmaceuticals (US), Former Director - Head of Privacy, Shire, Philadelphia, PA	John Patrick Oroho, JD Executive Vice President and Chief Strategy Officer, Porzio Life Sciences, LLC, Principal, Porzio, Bromberg & Newman PC, Morristown, NJ	Amy Pawloski Compliance Officer - Operations at Endo Pharmaceuticals, Former Global Lead, Compliance Risk Mitigation and Monitoring Strategy, Bristol-Myers Squibb; Philadelphia, PA	Joe Philipose, JD Vice President, US & Enterprise Compliance, Alexion, Former Director of Compliance, Salix, Former Director, PwC Life Sciences Consulting, Boston, MA
Roy Pollitt Managing Director, Americas Head, Investigations, Exiger, Former Special Agent, Federal Bureau of Investigation, New York, NY	Perri Pomper Director - Ethics and Compliance Strategy & Education at Novo Nordisk	Kelly N. "Nikki" Reeves, MPA, JD Partner, King & Spalding LLP, Washington, DC	Jeffrey Rosenbaum, MBA Partner and Co-founder, Dovetail Consulting Group, LLC, Former SVP, Chief Compliance and Risk Officer, Shire, Boston, MA
David Ryan, JD Vice President and Chief Compliance Officer, Epizyme, Former Vice President, Associate GC and CCO, Haemonetics, Former Vice President of Legal Affairs, Assistant General Counsel and CCO, AMAG Pharmaceuticals, Boston, MA	Mark Scallon, MHA Senior Principal, Polaris, IQVIA Global Compliance, Richmond, VA	Philip Lo Scalzo, JD Senior Vice President, Chief Compliance Officer, BioMarin; Former Assistant General Counsel, sanofi-aventis, Novato, CA	Cheryl J. Scarboro, JD Partner, Simpson Thacher & Bartlett, Former, Chief, FCPA Unit, Enforcement Division, US SEC, Washington, DC
Sue Seferian, JD Health Care Compliance Officer, Johnson & Johnson, Titusville, NJ	George Serafin, MS National Health Care and Life Sciences Leader, Grant Thornton, LLP, Iselin, NJ	Nicole Serena Director, Patient Access, Bayer, Canada	Patterson Shafer Managing Director, Health Care and Life Sciences, Grant Thornton, Stamford, CT
Michael Shaw, JD Vice President and Compliance Officer, US Pharmaceuticals, GlaxoSmithKline, Former Senior Counsel, Office of Inspector General, US DHHS, Former PCF Co-chair, Philadelphia, PA	Laura (Munns) Skinner, MBA Senior Manager, Life Sciences Advisory, Deloitte, Austin, TX	John Smollen, MA, JD Practice Professor of Law and Director, Center for Compliance and Ethics, Temple Law, Former EVP and CCO, Endo International, Philadelphia, PA	Eugene F. Soltes, MBA, PhD Jakurski Family Associate Professor of Business Administration, Harvard Business School, Author, Why They Do It: Inside the Mind of the White-Collar Criminal, Cambridge, MA
Oliver Steck Principal, Life Sciences Regulatory and Operational Risk, Deloitte & Touche LLP, New York, NY	Silvija A. Strikis, JD Partner, Kellogg Hansen Todd, Figel & Frederick, Former Law Clerk, Justice Sandra Day O'Connor, US Supreme Court, Washington, DC	Ravi Tayi, MD, MPH Chief Medical Officer, US Ferring Pharmaceuticals; Former Vice President, Global Medical Affairs, Mallinckrodt; Former Vice President, Medical Affairs and Clinical Development, Cubist/Optimer, New York, NY	Ann-Marie Tejcek, MA Senior Director, Ethics & Compliance, Eli Lilly and Company, Indianapolis, IN
Yuet Ming Tham, JD Partner and Global Head of White Collar Group, Sidley Austin, LLP, Former Asia Pacific Regional Compliance Director, Pfizer, Singapore and Hong Kong	Bryan Timer, MA Business Analytics Director, Data Analytics & Transparency, Merck, North Wales, PA	Brian Van Hoy Vice President, G&M Health LLC, Former Director, Ethics and Compliance, Eli Lilly, Bridgewater, NJ	Jennifer Vondee, MPH Manager, Pharmaceutical & Life Sciences Risk Consulting, PwC, Durham, NC
Julie Ritchie Wagner, JD Assistant General Counsel, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US Department of Health and Human Services; Washington, DC	Lisa Walkush, EMTM Partner, Grant Thornton, LLP, Philadelphia, PA	William Weinreb, JD Partner, Quinn Emanuel, Former Acting United States Attorney and First Assistant US Attorney, Boston, Boston, MA	Sarah Whipple, JD Senior Corporate and Compliance Counsel, Akebia Therapeutics, Inc., Former VP, Global Compliance & Privacy Officer, Aegerion, Former CCO and Assoc. GC, AMAG, Boston, MA
Donna White Vice President, Contracts & Compliance, Chiesi USA, Inc., Former Sr. Director, Contracts and Compliance, Cornerstone Therapeutics, Cary, NC	Seth B. Whitelaw, JD, LLM, SJD President and Chief Executive Officer, Whitelaw Compliance Group, LLC, Editor, Life Science Compliance Update, West Chester, PA	Jonathan Wilkenfeld, MBA Partner, Potomac River Partners, Washington, DC	Kathryn "Katie" E. Winson Senior Manager, US HCC Monitoring, Celgene Corporation, Summit, NJ

2018 GLOBAL PHARMA COMPLIANCE CONGRESSES

TWELFTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS

Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Media Partners: Life Sciences Compliance Update
May 14 - 16, 2018
Hotel Savoyen
Vienna, Austria
www.International PharmaCongress.com

EIGHTH ASIA PACIFIC PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS

Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS)
Media Partners: Life Sciences Compliance Update
September 10 - 12, 2018
Singapore
www.Asian PharmaCongress.com

NINETEENTH ANNUAL PHARMACEUTICAL AND
MEDICAL DEVICE COMPLIANCE CONGRESS

A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum (PCF)
November 7 - 9, 2018
Mandarin Oriental
Washington, DC
www.PharmaCongress.com

SPONSORED BY

The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 70 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs.

CONGRESS CO CHAIRS

Michael R. Clarke, JD
Vice President, Corporate Compliance, Indivior Inc., Richmond, VA
(PCF Co-Chair)

Sujata T. Dayal, JD
Vice President, Health Care Compliance & Privacy, Pharmaceuticals Group, Johnson & Johnson, Titusville, NJ
(PCF Secretary)

Jeffrey M. Kawalek, MBA
Senior Director, Ethics & Compliance, North America, Ipsen Biopharmaceuticals, Inc., Basking Ridge, NJ
(PCF Chair)

Jennifer McGee, JD
Vice President and Chief Compliance Officer, Otsuka America Pharmaceutical, Inc., Rockville, MD
(PCF Treasurer)

Margaret Sparks, JD
Associate Vice President, North America Ethics and Business Integrity, Sanofi US, Bridgewater, NJ
(PCF Co-Chair)

Joe Zimmerman
Vice President and Chief Compliance Officer US, Ferring Pharmaceuticals, Parsippany, NJ
(PCF Co-Chair)

GRANTORS:

GOLD

SILVER

BRONZE

CONTINUING EDUCATION CREDITS

Accounting Professionals: Approved for up to 19.0 NASBA CPE Credits.

Attorneys: The Congress is currently pending approval to offer Pennsylvania MCLE Credit.

Compliance Professionals: This education activity has been submitted to the Compliance Certification Board (CCB)® and is currently pending their review for approval of CCB CEUs.

Click here for more information.

MEDIA PARTNERS:

PLANNING COMMITTEE

CO-CHAIRS

Michael R. Clarke, JD
Vice President, Corporate Compliance, Indivior Inc. (PCF Co-Chair)

Sujata T. Dayal, JD
Vice President, Health Care Compliance and Privacy, Pharmaceuticals Group, Johnson & Johnson (PCF Secretary)

Jeffrey M. Kawalek, MBA
Senior Director, Ethics and Compliance, North America, Ipsen Biopharmaceuticals, Inc. (PCF Chair)

Jennifer McGee, JD
Vice President and Chief Compliance Officer, Otsuka America Pharmaceutical, Inc. (PCF Treasurer)

Margaret Sparks, JD
Associate Vice President, North America Ethics and Business Integrity, Sanofi US (PCF Co-Chair)

Joe Zimmerman
Vice President and Chief Compliance Officer US, Ferring Pharmaceuticals (PCF Co-Chair)

MEMBERS

Kamil Ali-Jackson, JD
Co-Founder, Chief Legal Officer, Chief Compliance Officer and Corporate Secretary, Aclaris Therapeutics, Inc.

Michael Arbini
Global Marketing Communications Leader, Polaris Management

Timothy Ayers
Group Vice President, Chief Compliance Officer, Horizon Pharma PLC

Dennis K. Barnes, JD, CPA
Vice President, Global Governance, Risk and Compliance, Mayne Pharma

Scott Bass, JD
Partner and Head, Global Life Sciences Team, Sidley Austin LLP

Ann E. Beasley, JD
Director, Navigant Consulting

John T. Bentivoglio, JD
Partner, Skadden Arps LLP

Kathleen M. Boozang, JD, LLM
Dean and Professor of Law, Seton Hall University School of Law

Scott Boyance
Associate Director, Forensic and Integrity Services, EY

Joseph Calarco
Chief Compliance Officer, Neos Therapeutics

Christie Camelio
Vice President and US Healthcare Compliance Officer, Celgene Corporation

Thomas Costa, JD
Member, US Board of Directors, Sanofi; Former Vice President, US Compliance and Ethics, Bristol-Myers Squibb

Paul Curtin, JD, CFE
Vice President, Global Chief Compliance Officer, Intercept Pharmaceuticals

Jill Fallows-Macaluso, BSN, JD
Vice President and Chief Compliance Officer, Novo Nordisk Inc.

Margaret K. Feltz, MA, JD
Vice President, Ethics and Compliance, Purdue Pharma LP

Alison Fethke, JD
Counsel, Ropes & Gray LLP

Alex Ganz, JD
Senior Manager of Compliance, Aegerion Pharmaceuticals

Gary F. Giampetruzzi, JD
Partner, Paul Hastings

Virginia "Ginny" A. Gibson, JD
Partner, Hogan Lovells

Jonathan Glazier, JD, MBA
Head of Legal Compliance, Philips North America LLC

Wendy C. Goldstein, JD
Partner, Health Care and Life Sciences Regulatory Practice, Cooley, LLP

Ive Grgas, MS
Director, Healthcare Compliance, Puma Biotechnology

Bill Hrubes, MS
Vice President and Chief Compliance Officer, ACell, Inc.

Erinn Hutchinson
Partner, Advisory Services, PwC

Michael Joachim, JD
Compliance Business Partner, Sanofi Genzyme

Jonathon L. Kellerman
Executive Vice President, Global Chief Compliance Officer, Allergan PLC

Daniel A. Kracov, JD
Partner and Head, FDA and Healthcare Practice, Arnold & Porter Kaye Scholer, LLP

Holly Kramen, JD
Chief Compliance Officer and Privacy Officer, PolarityTE

Puja Leekha, JD
Vice President, Chief Compliance Officer and Corporate Counsel, Corporate Compliance Lundbeck

Gregory Moss, JD
Senior Vice President, Deputy General Counsel, Kadmon Corporation

Katherine Norris
Director, Berkeley Research Group

Neil F. O'Flaherty, JD
Partner, Baker Mckenzie

John Patrick Oroho, JD
Executive Vice President and Chief Strategy Officer, Porzio Life Sciences, LLC

Jennifer O'Toole
Events Manager, Americas, SAI Global

Amy Pawloski
Compliance Officer, Operations, Endo Pharmaceuticals

Lori Queisser
Senior Vice President and Global Chief Compliance Officer, Teva

David Ralston, JD, MPH
Senior Director, Associate General Counsel, Business Conduct, Gilead Sciences

Kelly N. "Nikki" Reeves, MPA, JD
Partner, King & Spalding

Jeffrey Rosenbaum, MBA
Partner, Dovetail Consulting Group, LLC

Michael Shaw, JD
Vice President and Compliance Officer, US Pharmaceuticals, GlaxoSmithKline

Paul J. Silver
Principal, Deloitte

Ann-Marie Tejcek
Senior Director, Ethics and Compliance, Eli Lilly and Company

Brian Van Hoy
Vice President, G&M Health LLC

Donna Wachman
National Industry Marketing Leader, Grant Thornton LLP

Julie Wagner, JD
Assistant General Counsel, PhRMA

Caroline West, JD
Global Chief Compliance Officer, Olympus Corporation

Donna White
Vice President, Contracts and Compliance, Chiesi USA, Inc.

Seth B. Whitelaw, JD, LLM, SJD
President and CEO, Whitelaw Compliance Group, LLC

STAY CONNECTED

Tweet using #PharmaCongress

PARTICIPATION OPTIONS

TRADITIONAL ONSITE ATTENDANCE

Simply register, travel to the conference city and attend in person.

Pros: subject matter immersion; professional networking opportunities; faculty interaction

LIVE AND ARCHIVED WEBCAST PARTICIPATION

Watch the conference in live streaming video over the Internet and at your convenience at any time 24/7 for the six months following the event.

The archived conference includes speaker videos and coordinated PowerPoint presentations.

Pros: Live digital feed and 24/7 Internet access for next six months; Accessible in office, at home or anywhere worldwide with Internet access; Avoid travel expense and hassle; No time away from the office

WEBCAST INTERFACE SAMPLE

Click here for a sample stream

PAST GLOBAL PHARMA COMPLIANCE CONGRESSES

2007 - Brussels

2008 - Paris

2009 - Rome

2010 - Berlin

2011 - Istanbul

2011 - Singapore

2012 - Budapest

2012 - Shanghai

2012 - São Paulo

2013 - Madrid

2013 - Kuala Lumpur

2014 - Dubai

2014 - Mexico City

2014 - Shanghai

2015 - Manila

2016 - Warsaw

2017 - Lisbon

2018 - Vienna

CONGRESS REGISTRATION

For Congress registration information, visit https://www.pharmacongress.com/registration/, email registration@hcconferences.com, or call 800-503-7419.

CONGRESS EXHIBIT & SPONSORSHIP INFORMATION

For sponsorship and exhibit information visit https://www.pharmacongress.com/promotional-opportunities/, or contact Justin Sorensen, Exhibit Manager, 206-452-0609 phone, 206-319-5303 fax, exhibits@hcconferences.com.